Cannabis Patent Case Stayed: Metronome v. Smartscience Analysis
What would you like to do next?
Choose your path based on your current needs:
📋 Case Summary
| Case Name | Metronome, LLC v. Smartscience Laboratories, Inc. |
| Case Number | 8:25-cv-01844 |
| Court | U.S. District Court for the Middle District of Florida |
| Duration | Jul 2025 – Oct 2025 107 days |
| Outcome | Administrative Stay – Bankruptcy |
| Patents at Issue | |
| Accused Products | Topical treatments incorporating cannabis-derived botanical drug products |
Case Overview
The Parties
⚖️ Plaintiff
A patent-holding entity asserting rights over cannabis-derived topical formulation technology.
🛡️ Defendant
A life sciences company whose products allegedly infringed Metronome’s patent, now in bankruptcy proceedings.
The Patent at Issue
This case centers on U.S. Patent No. US10653736B2, covering topical treatments incorporating cannabis-derived botanical drug products:
- • US10653736B2 — Topical treatments incorporating cannabis-derived botanical drug products for topical application.
Developing a cannabis topical product?
Check if your formulation might infringe this or related patents.
The Verdict & Legal Analysis
Outcome: Administrative Stay Due to Bankruptcy
The Court directed the Clerk to stay and administratively close Case No. 8:25-cv-01844 in response to Smartscience Laboratories’ pending bankruptcy proceedings. This is not a verdict on the merits of infringement or patent validity. The court imposed structured reporting obligations, with Metronome’s lead counsel required to file status reports on the bankruptcy proceedings.
Why the Bankruptcy Stay Controls
Under 11 U.S.C. § 362, the filing of a bankruptcy petition triggers an automatic stay of virtually all civil litigation against the debtor. Patent infringement claims are not exempt. When Smartscience filed for bankruptcy, the automatic stay immediately halted Metronome’s ability to pursue monetary damages or injunctive relief in district court without first obtaining relief from the bankruptcy court.
Legal Significance for Cannabis Patent Litigation
This case highlights a structural risk in asserting patents against companies in volatile market sectors like cannabinoid therapeutics. Patent plaintiffs targeting companies in this space face real exposure to bankruptcy-triggered stays that can substantially delay or diminish recovery.
Strategic Takeaways
For Patent Holders: Conduct financial due diligence on defendants before filing to assess bankruptcy risk; consider whether filing earlier or pursuing emergency injunctive relief might preserve leverage. In bankruptcy proceedings, promptly file a proof of claim and evaluate seeking relief from the automatic stay under § 362(d) where infringement is ongoing.
For Accused Infringers: Bankruptcy reorganization can provide significant breathing room from patent enforcement actions. Coordination between bankruptcy counsel and patent litigation counsel is essential to manage automatic stay implications strategically.
For R&D Teams: Freedom-to-operate (FTO) analysis for cannabis topical formulations must account for US10653736B2 and related portfolio patents. Product development in the cannabinoid therapeutics space requires careful claim mapping against active patent assertions.
Filing a cannabis patent?
Learn from this case. Use AI to draft stronger claims and navigate the evolving cannabis IP landscape.
Power Your Patent Strategy with Eureka IP
From novelty searches to patent drafting, Eureka’s AI-powered tools help you navigate the patent landscape with confidence.
⚠️ Freedom to Operate (FTO) Analysis
This case highlights critical IP risks in the rapidly expanding cannabinoid therapeutics space. Choose your next step:
📋 Understand Cannabis IP Risks
Learn about the specific risks and implications from this litigation.
- View the specific claims of US10653736B2
- Identify other active patents in cannabis topicals
- Understand implications of bankruptcy stays on litigation
🔍 Check My Product’s Risk
Run a comprehensive FTO analysis for your own technology or product.
- Input your product description or technical features
- AI identifies potentially blocking patents
- Get actionable risk assessment report
High Risk Area
Cannabis-derived topical formulations
US10653736B2
Key patent in topical cannabis
Insolvency Impact
Litigation delays & reduced recovery
✅ Key Takeaways
For Patent Attorneys & Litigators
Cannabis sector defendants carry elevated bankruptcy risk — pre-filing financial diligence is essential.
Search related case law →Administrative stays under § 362 do not resolve infringement or validity; the underlying merits remain open.
Explore precedents →Plaintiffs must transition to creditor strategy in bankruptcy court, including timely proof of claim filing.
Learn more about creditor strategy →For IP Professionals
US10653736B2 remains an active enforcement asset in the cannabis topical treatment space.
View patent details →Monitor Smartscience’s bankruptcy docket for resolution timing and asset disposition.
Track related cases →For R&D Teams
Conduct targeted FTO analysis against US10653736B2 before commercializing cannabis-derived botanical topical formulations.
Start FTO analysis for my product →Assess supply chain exposure — not just direct infringement, but potential contributory or induced infringement risk.
Try AI patent drafting →Ready to Strengthen Your Patent Strategy?
Join thousands of IP professionals using Eureka to conduct prior art searches, draft patents, and analyze competitive landscapes.